CORBUS PHARMACEUTICALS HOLDINGS INC. - COMMON STO

Corbus Pharmaceuticals Reports Second Quarter 2024 Financial Results and Provides a Corporate Update

06 8 2024 07:00:00 提供 Nasdaq GlobeNewswire

NetDania - New 12 months High: CORBUS PHARMACEUTICALS HOLDINGS INC. - COMMON STO

31 7 2024 09:44:31 提供 NetDania Notify

Corbus Pharmaceuticals to Participate in Upcoming Investor Conferences in August

30 7 2024 07:50:40 提供 Nasdaq GlobeNewswire

NetDania - New 12 months High: CORBUS PHARMACEUTICALS HOLDINGS INC. - COMMON STO

16 7 2024 08:55:39 提供 NetDania Notify

NetDania - New 12 months High: CORBUS PHARMACEUTICALS HOLDINGS INC. - COMMON STO

15 7 2024 09:01:36 提供 NetDania Notify

NetDania - New 12 months High: CORBUS PHARMACEUTICALS HOLDINGS INC. - COMMON STO

12 7 2024 09:50:10 提供 NetDania Notify

NetDania - New 12 months High: CORBUS PHARMACEUTICALS HOLDINGS INC. - COMMON STO

12 6 2024 08:45:05 提供 NetDania Notify

NetDania - New 12 months High: CORBUS PHARMACEUTICALS HOLDINGS INC. - COMMON STO

11 6 2024 15:10:04 提供 NetDania Notify

NetDania - New 12 months High: CORBUS PHARMACEUTICALS HOLDINGS INC. - COMMON STO

03 6 2024 09:16:45 提供 NetDania Notify

SYS6002 (CRB-701) A Next-Generation Nectin-4 Targeting Antibody Drug Conjugate Continues to Demonstrate Encouraging Safety and Efficacy Observed in Patients with Nectin-4 Positive Tumors in a Clinical Update Presented at ASCO 2024

01 6 2024 09:00:00 提供 Nasdaq GlobeNewswire

Corbus Pharmaceuticals to Present at the 45th Annual Goldman Sachs Global Healthcare Conference

30 5 2024 07:00:00 提供 Nasdaq GlobeNewswire

Updated Phase 1 Clinical Data for SYS-6002 (CRB-701) to be presented at 2024 ASCO Annual Meeting

23 5 2024 16:05:26 提供 Nasdaq GlobeNewswire

NetDania - New 12 months High: CORBUS PHARMACEUTICALS HOLDINGS INC. - COMMON STO

21 5 2024 09:10:19 提供 NetDania Notify

Corbus Pharmaceuticals to Participate in the 2024 RBC Capital Markets Global Healthcare Conference

09 5 2024 07:00:00 提供 Nasdaq GlobeNewswire

Corbus Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Corporate Update

07 5 2024 07:00:01 提供 Nasdaq GlobeNewswire

Corbus Pharmaceuticals to Participate in the BTIG Obesity Health Forum

01 5 2024 07:00:01 提供 Nasdaq GlobeNewswire

Corbus Pharmaceuticals Announces Abstract Accepted for Presentation at 2024 ASCO Annual Meeting

24 4 2024 15:05:00 提供 Nasdaq GlobeNewswire

Corbus Announces Dosing of First Patient in U.S. Phase 1 Clinical Trial of Its Next Generation Nectin-4 Targeting ADC

02 4 2024 07:01:11 提供 Nasdaq GlobeNewswire

NetDania - New 12 months High: CORBUS PHARMACEUTICALS HOLDINGS INC. - COMMON STO

13 3 2024 08:45:14 提供 NetDania Notify

Corbus Pharmaceuticals Reports Fourth Quarter and Year-End 2023 Financial Results and Provides Corporate Update

12 3 2024 07:00:00 提供 Nasdaq GlobeNewswire